Skip to content

KZIA

Kazia Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$7.85
+8.28%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
3.40x
Price / sales
8010.05x
Price / cash flow
-11.95x

Enterprise value

Enterprise value
$61.7M
EV / sales
4494.45x
EV / EBITDA
-4.88x
EV / EBIT
-4.88x
Market cap
$110.0M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025